 Robert Kowalski
Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries, Traumatic | 9 | 2023 | 453 | 2.170 |
Why?
| | Brain Ischemia | 4 | 2025 | 359 | 1.680 |
Why?
| | Subarachnoid Hemorrhage | 14 | 2015 | 71 | 1.490 |
Why?
| | Consciousness | 4 | 2022 | 35 | 1.460 |
Why?
| | Brain Injuries | 7 | 2023 | 507 | 1.280 |
Why?
| | Stroke | 6 | 2023 | 1271 | 0.940 |
Why?
| | Interleukin-6 | 2 | 2025 | 779 | 0.800 |
Why?
| | Glasgow Coma Scale | 6 | 2016 | 218 | 0.740 |
Why?
| | Ischemic Attack, Transient | 1 | 2023 | 71 | 0.710 |
Why?
| | Recovery of Function | 4 | 2021 | 716 | 0.680 |
Why?
| | Hospital Mortality | 6 | 2015 | 1038 | 0.670 |
Why?
| | Neurological Rehabilitation | 1 | 2021 | 13 | 0.660 |
Why?
| | Music Therapy | 1 | 2021 | 24 | 0.660 |
Why?
| | Acoustic Stimulation | 1 | 2021 | 333 | 0.600 |
Why?
| | Gait | 1 | 2021 | 312 | 0.530 |
Why?
| | Status Epilepticus | 2 | 2020 | 68 | 0.500 |
Why?
| | Intracranial Aneurysm | 3 | 2015 | 106 | 0.480 |
Why?
| | Cerebrospinal Fluid Shunts | 1 | 2016 | 34 | 0.480 |
Why?
| | Exercise Therapy | 1 | 2021 | 475 | 0.470 |
Why?
| | Prognosis | 10 | 2023 | 4329 | 0.450 |
Why?
| | Coma | 2 | 2015 | 38 | 0.450 |
Why?
| | Hydrocephalus | 1 | 2016 | 111 | 0.450 |
Why?
| | Consciousness Disorders | 4 | 2023 | 25 | 0.410 |
Why?
| | Wakefulness | 1 | 2015 | 170 | 0.390 |
Why?
| | Life Support Care | 1 | 2013 | 42 | 0.390 |
Why?
| | Pentobarbital | 2 | 2012 | 17 | 0.390 |
Why?
| | Aged | 26 | 2025 | 26215 | 0.380 |
Why?
| | Middle Aged | 31 | 2025 | 36302 | 0.380 |
Why?
| | Tomography, X-Ray Computed | 6 | 2019 | 2770 | 0.380 |
Why?
| | Severity of Illness Index | 3 | 2017 | 2933 | 0.350 |
Why?
| | Vasoconstrictor Agents | 1 | 2012 | 150 | 0.340 |
Why?
| | Brain Edema | 1 | 2011 | 62 | 0.330 |
Why?
| | Anticonvulsants | 2 | 2012 | 246 | 0.320 |
Why?
| | Aged, 80 and over | 9 | 2025 | 8346 | 0.310 |
Why?
| | Predictive Value of Tests | 11 | 2023 | 2123 | 0.310 |
Why?
| | Adult | 27 | 2023 | 40872 | 0.310 |
Why?
| | Male | 36 | 2025 | 73003 | 0.300 |
Why?
| | Tissue Plasminogen Activator | 2 | 2023 | 248 | 0.300 |
Why?
| | Female | 37 | 2025 | 79035 | 0.290 |
Why?
| | Rehabilitation Centers | 2 | 2021 | 39 | 0.290 |
Why?
| | Mobile Health Units | 2 | 2019 | 20 | 0.280 |
Why?
| | Intensive Care Units | 6 | 2020 | 924 | 0.280 |
Why?
| | Brain | 3 | 2019 | 2969 | 0.270 |
Why?
| | Cohort Studies | 9 | 2021 | 6032 | 0.260 |
Why?
| | Respiration, Artificial | 1 | 2012 | 714 | 0.260 |
Why?
| | Humans | 46 | 2025 | 145763 | 0.250 |
Why?
| | Pulmonary Embolism | 2 | 2020 | 241 | 0.250 |
Why?
| | Heart Arrest | 1 | 2011 | 411 | 0.250 |
Why?
| | Treatment Outcome | 9 | 2023 | 11793 | 0.240 |
Why?
| | Venous Thromboembolism | 2 | 2020 | 328 | 0.220 |
Why?
| | Disability Evaluation | 4 | 2022 | 311 | 0.210 |
Why?
| | Patient Discharge | 3 | 2021 | 995 | 0.210 |
Why?
| | Incidence | 5 | 2017 | 2933 | 0.200 |
Why?
| | Cocaine-Related Disorders | 3 | 2015 | 133 | 0.200 |
Why?
| | Age Factors | 8 | 2019 | 3346 | 0.190 |
Why?
| | Hospitalization | 3 | 2021 | 2460 | 0.190 |
Why?
| | Critical Illness | 4 | 2020 | 900 | 0.190 |
Why?
| | Diagnostic Errors | 1 | 2004 | 178 | 0.180 |
Why?
| | Prospective Studies | 8 | 2017 | 8075 | 0.180 |
Why?
| | Databases, Factual | 3 | 2017 | 1491 | 0.180 |
Why?
| | Time Factors | 4 | 2025 | 7133 | 0.170 |
Why?
| | Critical Care | 4 | 2015 | 702 | 0.170 |
Why?
| | Retrospective Studies | 13 | 2020 | 17325 | 0.160 |
Why?
| | Sensitivity and Specificity | 1 | 2025 | 2000 | 0.160 |
Why?
| | Retinal Artery Occlusion | 1 | 2020 | 10 | 0.160 |
Why?
| | Fever | 3 | 2007 | 319 | 0.160 |
Why?
| | Product Labeling | 1 | 2020 | 11 | 0.160 |
Why?
| | Health Care Sector | 1 | 2020 | 26 | 0.160 |
Why?
| | Drug Labeling | 1 | 2020 | 37 | 0.160 |
Why?
| | Health Information Exchange | 1 | 2020 | 23 | 0.160 |
Why?
| | Return to Work | 1 | 2020 | 21 | 0.160 |
Why?
| | Spinal Cord Injuries | 2 | 2016 | 235 | 0.150 |
Why?
| | Physical Therapy Modalities | 2 | 2021 | 337 | 0.150 |
Why?
| | Access to Information | 1 | 2020 | 48 | 0.150 |
Why?
| | Seizures | 3 | 2020 | 485 | 0.150 |
Why?
| | Posture | 1 | 2021 | 197 | 0.150 |
Why?
| | Teleradiology | 1 | 2019 | 5 | 0.150 |
Why?
| | Wireless Technology | 1 | 2019 | 18 | 0.150 |
Why?
| | Systems Integration | 1 | 2019 | 36 | 0.150 |
Why?
| | Time-to-Treatment | 2 | 2019 | 251 | 0.150 |
Why?
| | Young Adult | 5 | 2021 | 14251 | 0.150 |
Why?
| | Ambulances | 1 | 2019 | 52 | 0.140 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 171 | 0.140 |
Why?
| | Fibrinolysis | 1 | 2020 | 164 | 0.140 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2019 | 92 | 0.140 |
Why?
| | Postural Balance | 1 | 2021 | 247 | 0.130 |
Why?
| | Multivariate Analysis | 3 | 2013 | 1547 | 0.130 |
Why?
| | Fibrinolytic Agents | 1 | 2020 | 297 | 0.130 |
Why?
| | Epilepsy | 2 | 2020 | 390 | 0.130 |
Why?
| | Neuroimaging | 2 | 2019 | 300 | 0.120 |
Why?
| | Amnesia | 1 | 2016 | 47 | 0.120 |
Why?
| | Acute Disease | 3 | 2015 | 1036 | 0.120 |
Why?
| | Risk Factors | 13 | 2020 | 10917 | 0.120 |
Why?
| | Walking | 1 | 2021 | 545 | 0.120 |
Why?
| | Body Temperature | 2 | 2007 | 227 | 0.110 |
Why?
| | Adolescent | 4 | 2021 | 22573 | 0.110 |
Why?
| | Pilot Projects | 1 | 2021 | 1897 | 0.110 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2015 | 58 | 0.110 |
Why?
| | Aneurysm, Ruptured | 2 | 2013 | 38 | 0.110 |
Why?
| | Hospitals, High-Volume | 1 | 2015 | 50 | 0.110 |
Why?
| | APACHE | 2 | 2012 | 68 | 0.100 |
Why?
| | Biomarkers | 1 | 2025 | 4302 | 0.100 |
Why?
| | Cold Temperature | 1 | 2015 | 206 | 0.100 |
Why?
| | Cytokines | 1 | 2021 | 2069 | 0.100 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 232 | 0.090 |
Why?
| | Seasons | 1 | 2015 | 538 | 0.090 |
Why?
| | Hospitals, Special | 1 | 2012 | 8 | 0.090 |
Why?
| | Nervous System Diseases | 1 | 2015 | 286 | 0.090 |
Why?
| | Cognition Disorders | 2 | 2014 | 544 | 0.090 |
Why?
| | Confidence Intervals | 1 | 2012 | 330 | 0.090 |
Why?
| | Patient Admission | 1 | 2013 | 220 | 0.090 |
Why?
| | Analysis of Variance | 2 | 2012 | 1300 | 0.090 |
Why?
| | Electroencephalography | 3 | 2020 | 563 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2019 | 1202 | 0.080 |
Why?
| | Length of Stay | 1 | 2016 | 1350 | 0.080 |
Why?
| | Comorbidity | 5 | 2015 | 1662 | 0.080 |
Why?
| | Emergency Service, Hospital | 2 | 2012 | 2383 | 0.080 |
Why?
| | Nerve Compression Syndromes | 1 | 2009 | 22 | 0.080 |
Why?
| | Neural Conduction | 1 | 2009 | 92 | 0.070 |
Why?
| | Biomedical Research | 1 | 2016 | 719 | 0.070 |
Why?
| | Academic Medical Centers | 1 | 2012 | 554 | 0.070 |
Why?
| | Patient Transfer | 1 | 2012 | 211 | 0.070 |
Why?
| | Survival Analysis | 1 | 2012 | 1378 | 0.070 |
Why?
| | Arm | 1 | 2009 | 110 | 0.070 |
Why?
| | Decision Support Techniques | 1 | 2013 | 480 | 0.070 |
Why?
| | Perioperative Care | 1 | 2011 | 231 | 0.070 |
Why?
| | Health Status Indicators | 2 | 2012 | 167 | 0.070 |
Why?
| | Thrombolytic Therapy | 2 | 2020 | 164 | 0.070 |
Why?
| | Monitoring, Intraoperative | 1 | 2008 | 66 | 0.070 |
Why?
| | Risk Assessment | 3 | 2013 | 3752 | 0.070 |
Why?
| | Inpatients | 3 | 2020 | 553 | 0.070 |
Why?
| | Hypothermia, Induced | 2 | 2007 | 96 | 0.060 |
Why?
| | Shivering | 1 | 2007 | 5 | 0.060 |
Why?
| | Propofol | 1 | 2008 | 85 | 0.060 |
Why?
| | Registries | 1 | 2016 | 2410 | 0.060 |
Why?
| | Follow-Up Studies | 2 | 2015 | 5428 | 0.060 |
Why?
| | Cryotherapy | 1 | 2007 | 21 | 0.060 |
Why?
| | Cerebral Infarction | 1 | 2007 | 47 | 0.060 |
Why?
| | Glasgow Outcome Scale | 2 | 2019 | 14 | 0.060 |
Why?
| | Logistic Models | 3 | 2020 | 2139 | 0.050 |
Why?
| | Sickness Impact Profile | 1 | 2004 | 62 | 0.050 |
Why?
| | Monitoring, Physiologic | 1 | 2004 | 289 | 0.040 |
Why?
| | Blood Pressure | 1 | 2009 | 1782 | 0.040 |
Why?
| | Government Regulation | 1 | 2020 | 39 | 0.040 |
Why?
| | Hypertension | 1 | 2009 | 1276 | 0.040 |
Why?
| | Policy Making | 1 | 2020 | 83 | 0.040 |
Why?
| | Diffusion of Innovation | 1 | 2020 | 96 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2020 | 172 | 0.040 |
Why?
| | Smoking Cessation | 1 | 2003 | 441 | 0.040 |
Why?
| | Hot Temperature | 2 | 2015 | 396 | 0.040 |
Why?
| | Chi-Square Distribution | 2 | 2013 | 528 | 0.040 |
Why?
| | Workflow | 1 | 2019 | 183 | 0.030 |
Why?
| | Odds Ratio | 2 | 2015 | 1083 | 0.030 |
Why?
| | ROC Curve | 2 | 2013 | 618 | 0.030 |
Why?
| | United States | 3 | 2020 | 16123 | 0.030 |
Why?
| | Injury Severity Score | 1 | 2019 | 599 | 0.030 |
Why?
| | Smoking | 1 | 2003 | 1477 | 0.030 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 303 | 0.030 |
Why?
| | Mid-Atlantic Region | 1 | 2015 | 3 | 0.030 |
Why?
| | Culture | 1 | 2016 | 124 | 0.030 |
Why?
| | Politics | 1 | 2016 | 92 | 0.030 |
Why?
| | Program Evaluation | 1 | 2019 | 944 | 0.030 |
Why?
| | Medicare | 1 | 2020 | 904 | 0.030 |
Why?
| | Anticoagulants | 1 | 2019 | 748 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2021 | 3634 | 0.020 |
Why?
| | Data Collection | 1 | 2016 | 643 | 0.020 |
Why?
| | Residence Characteristics | 1 | 2016 | 375 | 0.020 |
Why?
| | Area Under Curve | 1 | 2013 | 332 | 0.020 |
Why?
| | Drug Monitoring | 2 | 2008 | 401 | 0.020 |
Why?
| | Sex Factors | 2 | 2009 | 2110 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2967 | 0.020 |
Why?
| | Educational Status | 1 | 2014 | 470 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1327 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2012 | 280 | 0.020 |
Why?
| | Carpal Tunnel Syndrome | 1 | 2009 | 29 | 0.020 |
Why?
| | Colorado | 1 | 2019 | 4556 | 0.020 |
Why?
| | Weights and Measures | 1 | 2008 | 7 | 0.020 |
Why?
| | Neurophysiology | 1 | 2008 | 13 | 0.020 |
Why?
| | Entropy | 1 | 2008 | 44 | 0.020 |
Why?
| | Anesthetics, Intravenous | 1 | 2008 | 69 | 0.020 |
Why?
| | Judgment | 1 | 2008 | 58 | 0.020 |
Why?
| | Awareness | 1 | 2008 | 110 | 0.020 |
Why?
| | Lateral Ventricles | 1 | 2007 | 32 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2008 | 428 | 0.020 |
Why?
| | Energy Transfer | 1 | 2007 | 48 | 0.020 |
Why?
| | Automation | 1 | 2007 | 104 | 0.020 |
Why?
| | Hyponatremia | 1 | 2007 | 43 | 0.020 |
Why?
| | Respiratory Mechanics | 1 | 2007 | 74 | 0.020 |
Why?
| | Clinical Competence | 1 | 2015 | 1247 | 0.020 |
Why?
| | Magnesium | 1 | 2007 | 157 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 2007 | 125 | 0.010 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2007 | 128 | 0.010 |
Why?
| | Equipment Safety | 1 | 2004 | 38 | 0.010 |
Why?
| | Antihypertensive Agents | 1 | 2009 | 521 | 0.010 |
Why?
| | Linear Models | 1 | 2007 | 849 | 0.010 |
Why?
| | Radiography | 1 | 2007 | 853 | 0.010 |
Why?
| | Acetaminophen | 1 | 2007 | 267 | 0.010 |
Why?
| | Observation | 1 | 2004 | 54 | 0.010 |
Why?
| | Probability | 1 | 2004 | 308 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2004 | 318 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2004 | 428 | 0.010 |
Why?
| | Body Temperature Regulation | 1 | 2004 | 105 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2008 | 2028 | 0.010 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2004 | 95 | 0.010 |
Why?
| | New York | 1 | 2003 | 128 | 0.010 |
Why?
| | Equipment Design | 1 | 2004 | 525 | 0.010 |
Why?
| | Brain Diseases | 1 | 2004 | 155 | 0.010 |
Why?
| | Heart Rate | 1 | 2007 | 856 | 0.010 |
Why?
| | Wounds and Injuries | 1 | 2011 | 962 | 0.010 |
Why?
| | Regression Analysis | 1 | 2004 | 1001 | 0.010 |
Why?
| | Recurrence | 1 | 2003 | 1139 | 0.010 |
Why?
| | Alcohol Drinking | 1 | 2003 | 843 | 0.010 |
Why?
| | Depression | 1 | 2003 | 1557 | 0.010 |
Why?
| | Infant | 1 | 2004 | 10090 | 0.000 |
Why?
| | Child, Preschool | 1 | 2004 | 11868 | 0.000 |
Why?
| | Child | 1 | 2004 | 22739 | 0.000 |
Why?
|
|
Kowalski's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|